UBS ASSET MANAGEMENT AMERICAS LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$241,349,000
+94.2%
21,549
+90.7%
0.00%
Q2 2017$124,267,000
+12.2%
11,2970.0%0.00%
Q1 2017$110,711,000
+90646.7%
11,2970.0%0.00%
Q4 2016$122,000
-65.0%
11,297
-66.9%
0.00%
Q3 2016$349,000
-21.6%
34,0970.0%0.00%
-100.0%
Q2 2016$445,000
+18.7%
34,0970.0%0.00%
Q1 2016$375,000
+10.0%
34,097
-8.1%
0.00%
Q4 2015$341,000
+32.7%
37,0970.0%0.00%
Q3 2015$257,000
-29.4%
37,0970.0%0.00%
Q2 2015$364,000
+35.8%
37,097
+22.4%
0.00%
Q1 2015$268,000
+4.7%
30,297
+3.8%
0.00%
Q4 2014$256,000
+42.2%
29,197
+11.5%
0.00%
Q3 2014$180,000
+30.4%
26,1970.0%0.00%
Q2 2014$138,000
+16.0%
26,1970.0%0.00%
Q1 2014$119,000
-9.8%
26,1970.0%0.00%
Q4 2013$132,000
-0.8%
26,1970.0%0.00%
Q3 2013$133,000
+2.3%
26,1970.0%0.00%
Q2 2013$130,00026,1970.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Sensato Investors LLC 1,564,682$10,859,0002.03%
Matarin Capital Management, LLC 274,291$1,903,580,0000.39%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 87,524$607,417,0000.36%
TFS CAPITAL LLC 323,415$2,245,0000.22%
Nantahala Capital Management 170,218$1,181,0000.16%
Ativo Capital Management LLC 74,338$592,0000.16%
MENTA CAPITAL LLC 111,985$777,0000.12%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 229,891$1,595,0000.11%
GSA CAPITAL PARTNERS LLP 270,888$1,880,0000.09%
BOOTHBAY FUND MANAGEMENT, LLC 25,644$178,0000.08%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders